NRX PHARMACEUTICALS INC (NRXP) Stock Earnings & Estimates
NASDAQ:NRXP - US6294442099 - Common Stock
2.64 USD
+0.11 (+4.35%)
2.68 USD
+0.04 (+1.52%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 231.16% | N/A 170.30% | N/A 262.28% | N/A 108.00% | N/A 1.65% | N/A 11.75% | N/A 0.35% | |||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | -94.428M | -44.331M 53.05% | -27.582M 37.78% | -19.699M 28.58% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -134.5K | -1.007M -648.33% | -713.2K 29.14% | -907.4K -27.23% | -94.43M -10,306.66% | -44.335M 53.05% | -27.587M 37.78% | -19.704M 28.58% | N/A 83.13% | N/A 960.85% | N/A 641.08% | N/A 305.38% | N/A 117.97% | N/A 1.28% | N/A 11.43% | N/A 0.61% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | -4.00 39.04% | -2.31 42.25% | N/A 92.05% | N/A 666.67% | N/A 167.16% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 34.62% | 0.25 132.68% | 0.12 156.67% | 0.16 151.55% | 0.19 328.01% | 0.23 -9.46% |
| Revenue Q2Q % growth | 7.778M | 17.969M | 34.817M | 35.736M | 35.736M 359.45% | 36.655M 103.99% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -945.877K 68.70% | 5.793M 259.41% | 15.899M 524.31% | 16.508M 491.33% | 16.508M 1,845.26% | 16.964M 192.84% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.31 53.73% | -0.21 | -0.10 | -49.47% |
| Q1 2025 Q2Q % growth | -0.21 71.62% | -0.31 | 0.10 | 31.37% |
| Q4 2024 Q2Q % growth | -0.77 -54.00% | -0.32 | -0.45 | -138.39% |
| Q3 2024 Q2Q % growth | -0.13 81.43% | -0.65 | 0.52 | 80.09% |
| Q2 2024 Q2Q % growth | -0.67 44.17% | -0.71 | 0.04 | 5.49% |
| Q1 2024 Q2Q % growth | -0.74 53.75% | -0.56 | -0.18 | -31.91% |
| Q4 2023 Q2Q % growth | -0.50 68.75% | -0.71 | 0.21 | 29.97% |
| Q3 2023 Q2Q % growth | -0.70 50.00% | -1.16 | 0.46 | 39.44% |
| Q2 2023 Q2Q % growth | -1.20 -9.09% | -1.39 | 0.19 | 13.92% |
| Q1 2023 Q2Q % growth | -1.60 -661.90% | -1.43 | -0.17 | -12.04% |
| Q4 2022 Q2Q % growth | -1.60 -1,677.78% | -1.48 | -0.12 | -8.18% |
| Q3 2022 Q2Q % growth | -1.40 -250.00% | -1.43 | 0.03 | 1.96% |
| Q2 2022 Q2Q % growth | -1.10 -189.47% | -1.02 | -0.08 | -7.84% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.53M | -1.53M | -100.00% | |
| Q1 2025 Q2Q % growth | 1.16M | -1.16M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 4.69% | -44% | N/A |
| Revenue | 0% | 0% | 0% | -4.69% |